GeoVax Labs Inc. Watch

from 8-K 43 pages GeoVax Labs, Inc. Common Stock Sales Agreement

from 8-K 32 pages Securities Purchase Agreement

from 8-K 22 pages Placement Agency Agreement

from 8-K 32 pages Securities Purchase Agreement

from 8-K 22 pages Placement Agency Agreement

from 10-Q 35 pages The Symbol “[***]” Denotes Places Where Certain Identified Information Has Been Excluded From the Exhibit Because: (I) the Company Has Determined the Omitted Information Is Not Material, and (II) the Company Customarily and Actually Treats the Omitted Information as Private or Confidential Rrpv Project Award Number: 001 Rrpv Project Title: Rrpv-24-04-Ngvx-006; Phase 2b Study to Evaluate Geo-Cm04s1 Covid-19 Vaccine Uei Number: Cef5ult44lf5 Parties: Advanced Technology International (Rrpv Consortium Management Firm or Cmf) and Geovax, Inc. (Project Awardee) 1. Payment Method the Payment Method for This Project Award Is Expenditure-Based Milestone With a Not to Exceed Ceiling. 2. Term of the Project Award the Period of Performance for This Project Award Is From the Effective Date, Which Is the Date of Last Signature, Through November 29, 2027. 3. Obligation the Cmf’s Liability to Make Payments to the Project Awardee Is Limited to Only Those Funds Obligated Under This Project Award or by Modification to the Project Award. the Cmf May Incrementally Fund This Project Award. 4. Estimated Cost the Total Estimated Costs Amount for the Services to Be Provided by the Project Awardee Are as Follows: Estimated Cost $24,321,841

from 10-Q 37 pages Article 1. Preamble

from 8-K 32 pages Securities Purchase Agreement

from 8-K 22 pages Placement Agency Agreement

from 8-K 32 pages Securities Purchase Agreement

from 8-K 22 pages Placement Agency Agreement

from 8-K 7 pages Holder of Common Stock Purchase Warrants Re: Inducement Offer to Exercise Common Stock Purchase Warrants Dear Holder

from 8-K 41 pages At the Market Offering Agreement July 18, 2023

from 10-Q 7 pages Amendment to Exclusive License Agreement

from 10-K 4 pages First Amendment to Office Lease Agreement

from 10-K 10 pages Amendment Number One to Employment Agreement

from 10-K 6 pages Employment Agreement Between Geovax, Inc. and Kelly T. McKee, Jr., M.D., Mph

from 8-K 23 pages Geovax Labs, Inc. 2023 Stock Incentive Plan 1 Geovax Labs, Inc. 2023 Stock Incentive Plan

from 10-Q 10 pages Amendment Number One to Employment Agreement

from 10-Q 6 pages Employment Agreement Between Geovax, Inc. and John W. Sharkey, Phd